recast-jats-builde082d6219ajitcJ Immunother Cancer40425Journal for ImmunoTherapy of CancerJ Immunother Cancer2051-1426BMJ Publishing Group Ltds40425-018-0410-241010.1186/s40425-018-0410-2/jitc/6/1/92.atomCorrectionCorrection to: CART cells are prone to Fas- and DR5-mediated cell deathTschumiBenjamin O.1DumauthiozNina1MartiBastien1ZhangLianjun1LanitisEvripidis23IrvingMelita23SchneiderPascal4MachJean-Pierre4CoukosGeorge23RomeroPedro1DondaAlena1k Department of Fundamental OncologyTranslational Tumor Immunology Group Lausanne Switzerland 0000 0001 0423 4662grid.8515.9Department of OncologyUniversity Hospital of Lausanne Lausanne Switzerland 0000 0001 2165 4204grid.9851.5Ludwig Institute for Cancer Research, Lausanne Branch Lausanne Switzerland 0000 0001 2165 4204grid.9851.5Department of Biochemistry, Faculty of Biology and MedicineUniversity of Lausanne Lausanne Switzerland Alena.donda@unil.ch 122018259201818112019181120192592018619214920181492018© The Author(s).2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

After publication of this article [1], it was noticed that 3 authors were missed from the author list.

publisher-imprint-nameBioMed Centralvolume-issue-count1issue-article-count0issue-toc-levels0issue-pricelist-year2018issue-copyright-holderThe Author(s)issue-copyright-year2018article-contains-esmNoarticle-numbering-styleUnnumberedarticle-registration-date-year2018article-registration-date-month9article-registration-date-day12article-toc-levels0toc-levels0volume-typeRegularjournal-productArchiveJournalnumbering-styleUnnumberedarticle-grants-typeOpenChoicemetadata-grantOpenAccessabstract-grantOpenAccessbodypdf-grantOpenAccessbodyhtml-grantOpenAccessbibliography-grantOpenAccessesm-grantOpenAccessonline-firstfalsepdf-file-referenceBodyRef/PDF/40425_2018_Article_410.pdfpdf-typeTypesettarget-typeOnlinePDFissue-typeRegulararticle-typeErratumjournal-subject-primaryMedicine & Public Healthjournal-subject-secondaryOncologyjournal-subject-secondaryImmunologyjournal-subject-collectionMedicine

The original article can be found online at 10.1186/s40425-018-0385-z

Correction

After publication of this article [1], it was noticed that 3 authors were missed from the author list. These authors are Evripidis Lanitis, Melita Irving and George Coukos. The correct author list can be seen above and updated Competing Interests, Authors’ Contributions and Acknowledgements can be seen below.

We are grateful to P. Reichenbach for sharing his expertise in DNA cloning strategies. Special thanks to Prof. M. Thome for sharing her expertise in the field of T cell signalling.

Authors’ contributions

AD and BT designed and developed the study. BT, ND, BM and LZ performed the experiments, acquired and analyzed the data. E.L. has set up the protocol of transduction of murine primary lymphocytes. EL, MI and GC contributed to the conception, experimental design and analysis of results. PS shared his expertise on programmed cell death and provided essential reagents. AD, BT, LZ, PR and JPM wrote the manuscript. All authors read and approved the final manuscript.

Competing interests

All co-authors declare that they have no competing interests.

Reference Tschumi BO , Dumauthioz N , Marti B , Zhang L , Schneider P , Mach J-P , et al . CART cells are prone to Fas- and DR5-mediated cell death. J Immuno Cancer. 2018;6:71 doi:10.1186/s40425-018-0385-z